Cancer News and Research

Latest Cancer News and Research

New ultra-specific test now available for prostate cancer

A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs.

27 Sep 2013

Icotinib matches gefitinib in NSCLC second or third line

Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.

26 Sep 2013

Anti-inflammatory drug ibuprofen may fight against certain cancers

Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing.

26 Sep 2013

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Astellas Pharma US, Inc. and Medivation, Inc. today announced results of a national survey of men with advanced prostate cancer and caregivers of men with advanced prostate cancer.

26 Sep 2013

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

From today, patients with a very aggressive form of breast cancer known as HER2-positive, could benefit from a new faster, more efficient delivery method of Herceptin. The subcutaneous injection, given just beneath the skin, can be completed in 2-5 minutes, compared to the traditional, relatively time-consuming 30-90 minute intravenous infusion.

26 Sep 2013

Celebrities join to mark the first Day of the Ex-Smoker

The day of celebration is to congratulate all ex-smokers, whether they are amongst the 400,000 who have signed up to kick the habit with the European Commission's "Ex-Smokers are Unstoppable" campaign, or have quit using other means.

26 Sep 2013

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma cancer patients treated with intensity modulated proton therapy decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy.

26 Sep 2013

VolitionRx enters into distribution agreement with Active Motif for NuQ product line

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today entered into an agreement with Active Motif, a leading provider of kits and reagents to enable epigenetics research.

26 Sep 2013

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Pittcon is pleased to announce it will be exhibiting at the next BioConference Live virtual event. BioConference Live, the largest producer of online-only conferences focused on life sciences, laboratory animal sciences and clinical diagnostics, has announced the upcoming “Cancer: Research, Discovery and Therapeutics” online-only conference.

26 Sep 2013

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.

26 Sep 2013

Study: Fruit and vegetable consumption reduces all-cause mortality

A European study analyzes the relationship between fruit and vegetable consumption and the risk of mortality. As previous research has already suggested, this study concludes that fruit and vegetable consumption reduces all-cause mortality, and especially cardiovascular disease mortality.

26 Sep 2013

Study evaluates reliability of scale to assess toxicity for patients receiving radiation therapy

The North Shore-LIJ Health System Department of Radiation Medicine presented a novel study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy. The study will be presented at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology in Atlanta, GA.

26 Sep 2013

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.

26 Sep 2013

Three research groups awarded NIH grants to develop framework for evaluating genetic variants

Three grants totaling more than $25 million over four years will help three research groups to develop authoritative information on the millions of genomic variants relevant to human disease and the hundreds that are expected to be useful for clinical practice. The awards are from the National Institutes of Health.

26 Sep 2013

Wayne State aims to develop advanced education program for radiation oncology

The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.

26 Sep 2013

Older women living in poorest areas of Appalachia have higher incidence of later stage breast cancer

Older women living in the poorest areas of Appalachia in the U.S. fail to get regular breast cancer screening and have a higher incidence of later stage breast cancer, reports a new study in Health Services Research.

26 Sep 2013

University of Michigan offers new test to improve PSA screening for prostate cancer

More than 1 million men will undergo a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.

26 Sep 2013

New animal model may help study immune responses to H. pylori infection

Researchers at the Virginia Bioinformatics Institute at Virginia Tech have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of peptic ulcer disease.

26 Sep 2013

Researchers identify existence of precursor cells in early prostate cancers

A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.

26 Sep 2013

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

26 Sep 2013

Cancer News and Research

Latest Cancer News and Research

New ultra-specific test now available for prostate cancer

Icotinib matches gefitinib in NSCLC second or third line

Anti-inflammatory drug ibuprofen may fight against certain cancers

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

Celebrities join to mark the first Day of the Ex-Smoker

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

VolitionRx enters into distribution agreement with Active Motif for NuQ product line

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

Study: Fruit and vegetable consumption reduces all-cause mortality

Study evaluates reliability of scale to assess toxicity for patients receiving radiation therapy

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

Three research groups awarded NIH grants to develop framework for evaluating genetic variants

Wayne State aims to develop advanced education program for radiation oncology

Older women living in poorest areas of Appalachia have higher incidence of later stage breast cancer

University of Michigan offers new test to improve PSA screening for prostate cancer

New animal model may help study immune responses to H. pylori infection

Researchers identify existence of precursor cells in early prostate cancers

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in